Recent Analysts’ Ratings Changes for GE HealthCare Technologies (GEHC)

GE HealthCare Technologies (NASDAQ: GEHC) has recently received a number of price target changes and ratings updates:

• 2/6/2026 – GE HealthCare Technologies had its price target raised by analysts at Barclays PLC from $86.00 to $87.00. They now have an “equal weight” rating on the stock.
• 2/5/2026 – GE HealthCare Technologies had its price target raised by analysts at Evercore Inc from $95.00 to $98.00. They now have an “outperform” rating on the stock.
• 2/5/2026 – GE HealthCare Technologies had its price target raised by analysts at Wells Fargo & Company from $95.00 to $97.00. They now have an “overweight” rating on the stock.
• 2/4/2026 – GE HealthCare Technologies had its price target raised by analysts at Stifel Nicolaus from $95.00 to $98.00. They now have a “buy” rating on the stock.
• 2/4/2026 – GE HealthCare Technologies had its price target raised by analysts at Morgan Stanley from $80.00 to $85.00. They now have an “equal weight” rating on the stock.
• 2/4/2026 – GE HealthCare Technologies had its price target raised by analysts at BTIG Research from $87.00 to $91.00. They now have a “buy” rating on the stock.
• 1/30/2026 – GE HealthCare Technologies had its price target raised by analysts at Piper Sandler from $91.00 to $94.00. They now have an “overweight” rating on the stock.
• 1/15/2026 – GE HealthCare Technologies was downgraded by analysts at UBS Group AG from a “neutral” rating to a “sell” rating. They now have a $77.00 price target on the stock, up previously from $73.00.
• 1/9/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $98.00 price target on the stock.
• 1/7/2026 – GE HealthCare Technologies had its price target raised by analysts at Stifel Nicolaus from $90.00 to $95.00. They now have a “buy” rating on the stock.
• 1/5/2026 – GE HealthCare Technologies had its “outperform” rating reaffirmed by analysts at Evercore Inc. They now have a $95.00 price target on the stock.
• 1/5/2026 – GE HealthCare Technologies had its price target raised by analysts at Bank of America Corporation from $82.00 to $92.00. They now have a “neutral” rating on the stock.
• 12/29/2025 – GE HealthCare Technologies had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – GE HealthCare Technologies had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.